Telerehabilitation for Patellofemoral Pain

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorBeijing Sport University

About this trial

Patellofemoral pain (PFP) is a common musculoskeletal condition characterized by pain around or behind the patella during activities such as stair ambulation, squatting, running, jumping, and prolonged sitting. Exercise therapy combined with patient education is considered first-line treatment, and supervised rehabilitation is commonly used to improve adherence and clinical outcomes.

Telerehabilitation may increase accessibility and reduce time and travel burden, but high-quality evidence remains limited regarding whether telerehabilitation provides outcomes that are not inferior to conventional face-to-face supervised rehabilitation in individuals with PFP.

This study is a randomized, assessor-blinded, non-inferiority trial designed to compare telerehabilitation with face-to-face supervised rehabilitation in individuals with patellofemoral pain. The trial will evaluate whether telerehabilitation is not inferior to face-to-face supervised rehabilitation in improving pain and knee-related function, while also examining psychological outcomes, self-satisfaction, and adherence.

Eligibility criteria

Qualifiers

* Aged 18 to 45 years

Clinical diagnosis of patellofemoral pain

History of anterior or retropatellar knee pain for at least 3 months

Pain provoked by at least two of the following activities: stair ambulation, squatting, running, jumping, or prolonged sitting

Disqualifiers

Previous knee surgery

History of patellar dislocation or instability

Evidence of ligament injury, meniscal injury requiring separate management, moderate to severe knee osteoarthritis, or other major structural knee pathology

Concurrent hip, ankle, lumbar spine, or other musculoskeletal disorders substantially affecting lower limb function

Trial design

Treatments tested in this trial

  • Telerehabilitation
  • Face-to-Face Rehabilitation

Treatment groups

106 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators